0001739614-21-000117.txt : 20211207 0001739614-21-000117.hdr.sgml : 20211207 20211207194302 ACCESSION NUMBER: 0001739614-21-000117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211207 FILED AS OF DATE: 20211207 DATE AS OF CHANGE: 20211207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vuori Kristiina MD CENTRAL INDEX KEY: 0001612627 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39452 FILM NUMBER: 211477309 MAIL ADDRESS: STREET 1: C/O WEBMD HEALTH CORP. STREET 2: 111 EIGHTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibrx, Inc. CENTRAL INDEX KEY: 0001739614 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 824257312 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 795-4220 MAIL ADDRESS: STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 wf-form4_163892416605245.xml FORM 4 X0306 4 2021-12-07 0 0001739614 Inhibrx, Inc. INBX 0001612627 Vuori Kristiina MD C/O INHIBRX, INC. 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 1 0 0 0 Stock Option (right to buy) 40.45 2021-12-07 4 A 0 30000 0 A 2031-12-07 Common Stock 30000.0 30000 D Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on December 7, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter. /s/ Kelly D. Deck, attorney-in-fact 2021-12-07